title: Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients.
abstract: Mechanisms of invasion in glioblastoma (GBM) relate to differential expression of proteins conferring increased motility and penetration of the extracellular matrix. CD97 is a member of the epidermal growth factor seven-span transmembrane family of adhesion G-protein coupled receptors. These proteins facilitate mobility of leukocytes into tissue. In this study we show that CD97 is expressed in glioma, has functional effects on invasion, and is associated with poor overall survival. Glioma cell lines and low passage primary cultures were analyzed. Functional significance was assessed by transient knockdown using siRNA targeting CD97 or a non-target control sequence. Invasion was assessed 48 hours after siRNA-mediated knockdown using a Matrigel-coated invasion chamber. Migration was quantified using a scratch assay over 12 hours. Proliferation was measured 24 and 48 hours after confirmed protein knockdown. GBM cell lines and primary cultures were found to express CD97. Knockdown of CD97 decreased invasion and migration in GBM cell lines, with no difference in proliferation. Gene-expression based Kaplan-Meier analysis was performed using The Cancer Genome Atlas, demonstrating an inverse relationship between CD97 expression and survival. GBMs expressing high levels of CD97 were associated with decreased survival compared to those with low CD97 (p = 0.007). CD97 promotes invasion and migration in GBM, but has no effect on tumor proliferation. This phenotype may explain the discrepancy in survival between high and low CD97-expressing tumors. This data provides impetus for further studies to determine its viability as a therapeutic target in the treatment of GBM.
authors: Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
authors: Michael
authors: M
authors: Safaee
authors: Aaron J
authors: AJ
authors: Clark
authors: Michael C
authors: MC
authors: Oh
authors: Michael E
authors: ME
authors: Ivan
authors: Orin
authors: O
authors: Bloch
authors: Gurvinder
authors: G
authors: Kaur
authors: Matthew Z
authors: MZ
authors: Sun
authors: Joseph M
authors: JM
authors: Kim
authors: Taemin
authors: T
authors: Oh
authors: Mitchel S
authors: MS
authors: Berger
authors: Andrew T
authors: AT
authors: Parsa
mesh_terms: D015703:Antigens, CD / Q000235:genetics* / Q000378:metabolism; D001932:Brain Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000401:mortality / Q000473:pathology; D045744:Cell Line, Tumor; D054443:Cell Migration Assays; D002465:Cell Movement; D049109:Cell Proliferation; D015972:Gene Expression Regulation, Neoplastic; D055785:Gene Knockdown Techniques; D005909:Glioblastoma / Q000235:genetics* / Q000378:metabolism / Q000401:mortality / Q000473:pathology; D006801:Humans; D009361:Neoplasm Invasiveness; D010641:Phenotype; D061251:Primary Cell Culture; D034741:RNA, Small Interfering / Q000235:genetics / Q000378:metabolism; D043562:Receptors, G-Protein-Coupled; D016019:Survival Analysis
chemical_list: C095004:ADGRE5 protein, human; D015703:Antigens, CD; D034741:RNA, Small Interfering; D043562:Receptors, G-Protein-Coupled
references: Int J Cancer. 2010 Sep 1;127(5):1240-8
references: 20099278
references: Acta Neurochir Suppl. 2003;88:163-7
references: 14531574
references: J Neurooncol. 2011 Sep;104(3):679-87
references: 21359852
references: Prostaglandins Other Lipid Mediat. 2010 Apr;91(3-4):130-8
references: 20331961
references: Genomics. 2000 Jul 15;67(2):188-200
references: 10903844
references: J Biol Chem. 2001 Jun 1;276(22):18863-70
references: 11279179
references: J Exp Med. 1996 Sep 1;184(3):1185-9
references: 9064337
references: J Neurooncol. 2012 Jan;106(1):147-53
references: 21739168
references: Arthritis Res Ther. 2006;8(5):R155
references: 17007638
references: J Biol Chem. 2001 Feb 9;276(6):4150-7
references: 11050079
references: Blood. 2005 Apr 1;105(7):2836-44
references: 15576472
references: J Neurooncol. 2006 Jul;78(3):295-302
references: 16636750
references: Am J Clin Pathol. 2002 Nov;118(5):699-707
references: 12428789
references: J Neurosurg. 2005 Apr;102(4):622-8
references: 15871503
references: J Neurosurg. 2003 Sep;99(3):467-73
references: 12959431
references: Clin Cancer Res. 1999 Apr;5(4):845-54
references: 10213221
references: J Immunol. 1996 Dec 15;157(12):5438-47
references: 8955192
references: Am J Pathol. 2006 Nov;169(5):1802-11
references: 17071601
references: Eur J Immunol. 1998 May;28(5):1701-7
references: 9603477
references: Trends Biochem Sci. 2008 Oct;33(10):491-500
references: 18789697
references: Cancer Res. 1991 Sep 15;51(18):4986-93
references: 1893386
references: J Immunol. 2001 Oct 1;167(7):3570-6
references: 11564768
references: Blood. 2003 Oct 15;102(8):2916-24
references: 12829604
references: Cancer Res. 1996 Apr 15;56(8):1939-47
references: 8620517
references: J Biol Chem. 2002 Aug 9;277(32):29283-93
references: 12023293
references: Eur J Endocrinol. 1995 Feb;132(2):229-35
references: 7858744
references: J Immunol. 1995 Aug 15;155(4):1942-50
references: 7636245
references: Tissue Antigens. 1997 Nov;50(5):429-38
references: 9389316
references: J Clin Endocrinol Metab. 1999 Mar;84(3):1104-9
references: 10084602
references: PLoS One. 2010 Jan 13;5(1):e8507
references: 20084281
references: Immunology. 1999 Oct;98(2):303-11
references: 10540231
references: J Neurooncol. 2011 Nov;105(2):165-71
references: 21503828
references: Cancer Res. 2011 Oct 15;71(20):6371-81
references: 21859829
references: J Neurosurg. 1961 Sep;18:636-44
references: 13768222
references: J Clin Oncol. 2002 Mar 1;20(5):1383-8
references: 11870183
references: Acta Neuropathol. 1999 Mar;97(3):231-9
references: 10090669
references: Am J Pathol. 2002 Nov;161(5):1657-67
references: 12414513
references: Anticancer Res. 1998 Jul-Aug;18(4A):2599-605
references: 9703915
references: J Neurosurg. 2012 Apr;116(4):843-53
references: 22313360
references: Int J Dev Neurosci. 1999 Aug-Oct;17(5-6):613-23
references: 10571422
references: Cancer Res. 1997 May 1;57(9):1798-806
references: 9135025
references: Oncogene. 2004 Jun 10;23(27):4681-9
references: 15122332
references: Neuroreport. 2010 Nov 17;21(16):1018-22
references: 20827226
references: Cancer Res. 2011 Dec 1;71(23):7301-11
references: 21978933
references: Thyroid. 2005 Mar;15(3):222-31
references: 15785241
references: N Engl J Med. 2005 Mar 10;352(10):987-96
references: 15758009
references: Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):108-19
references: 15668483